These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26121746)

  • 1. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.
    Vendruscolo LF; Estey D; Goodell V; Macshane LG; Logrip ML; Schlosburg JE; McGinn MA; Zamora-Martinez ER; Belanoff JK; Hunt HJ; Sanna PP; George O; Koob GF; Edwards S; Mason BJ
    J Clin Invest; 2015 Aug; 125(8):3193-7. PubMed ID: 26121746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats.
    Khom S; Rodriguez L; Gandhi P; Kirson D; Bajo M; Oleata CS; Vendruscolo LF; Mason BJ; Roberto M
    Neurobiol Dis; 2022 Mar; 164():105610. PubMed ID: 34995754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Glucocorticoid Receptor Antagonism on Alcohol Self-Administration in Genetically-Selected Marchigian Sardinian Alcohol-Preferring and Non-Preferring Wistar Rats.
    Benvenuti F; Cannella N; Stopponi S; Soverchia L; Ubaldi M; Lunerti V; Vozella V; Cruz B; Roberto M; Ciccocioppo R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP5 mRNA Expression Is a Biomarker for GR Antagonism.
    Bali U; Phillips T; Hunt H; Unitt J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4305-4312. PubMed ID: 27459525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Glucocorticoid Receptor Reduces Binge-Like Drinking in High Drinking in the Dark (HDID-1) Mice.
    Savarese AM; Ozburn AR; Metten P; Schlumbohm JP; Hack WR; LeMoine K; Hunt H; Hausch F; Bauder M; Crabbe JC
    Alcohol Clin Exp Res; 2020 May; 44(5):1025-1036. PubMed ID: 32154593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral mifepristone for chronic central serous chorioretinopathy.
    Nielsen JS; Jampol LM
    Retina; 2011 Oct; 31(9):1928-36. PubMed ID: 21878843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.
    Vendruscolo LF; Barbier E; Schlosburg JE; Misra KK; Whitfield TW; Logrip ML; Rivier C; Repunte-Canonigo V; Zorrilla EP; Sanna PP; Heilig M; Koob GF
    J Neurosci; 2012 May; 32(22):7563-71. PubMed ID: 22649234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol.
    Donoghue K; Rose A; Coulton S; Milward J; Reed K; Drummond C; Little H
    BMC Psychiatry; 2016 Feb; 16():40. PubMed ID: 26912003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study.
    Haass-Koffler CL; Magill M; Cannella N; Brown JC; Aoun EG; Cioe PA; Sinha R; Swift RM; Ciccocioppo R; Leggio L
    Addict Biol; 2023 Jul; 28(7):e13288. PubMed ID: 37369125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions.
    Koenig HN; Olive MF
    Psychoneuroendocrinology; 2004 Sep; 29(8):999-1003. PubMed ID: 15219650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
    Fleseriu M; Biller BM; Findling JW; Molitch ME; Schteingart DE; Gross C;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2039-49. PubMed ID: 22466348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor modulators decrease alcohol self-administration in male rats.
    McGinn MA; Tunstall BJ; Schlosburg JE; Gregory-Flores A; George O; de Guglielmo G; Mason BJ; Hunt HJ; Koob GF; Vendruscolo LF
    Neuropharmacology; 2021 May; 188():108510. PubMed ID: 33647278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of mifepristone effects on alcohol-seeking and self-administration in baboons.
    Holtyn AF; Weerts EM
    Exp Clin Psychopharmacol; 2019 Jun; 27(3):227-235. PubMed ID: 30570274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats.
    Vozella V; Cruz B; Natividad LA; Benvenuti F; Cannella N; Edwards S; Zorrilla EP; Ciccocioppo R; Roberto M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption.
    Jacquot C; Croft AP; Prendergast MA; Mulholland P; Shaw SG; Little HJ
    Alcohol Clin Exp Res; 2008 Dec; 32(12):2107-16. PubMed ID: 18828802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone for management of Cushing's syndrome.
    Morgan FH; Laufgraben MJ
    Pharmacotherapy; 2013 Mar; 33(3):319-29. PubMed ID: 23436494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripubertal stress-induced heightened aggression: modulation of the glucocorticoid receptor in the central amygdala and normalization by mifepristone treatment.
    Papilloud A; Veenit V; Tzanoulinou S; Riccio O; Zanoletti O; Guillot de Suduiraut I; Grosse J; Sandi C
    Neuropsychopharmacology; 2019 Mar; 44(4):674-682. PubMed ID: 29941978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatile Cortisol Feedback on ACTH Secretion Is Mediated by the Glucocorticoid Receptor and Modulated by Gender.
    Roelfsema F; Aoun P; Veldhuis JD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4094-4102. PubMed ID: 27548106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist.
    Sorensen BK; Link JT; von Geldern T; Emery M; Wang J; Hickman B; Grynfarb M; Goos-Nilsson A; Carroll S
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2307-10. PubMed ID: 12824023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
    Breivik T; Gundersen Y; Gjermo P; Opstad PK
    J Periodontal Res; 2014 Feb; 49(1):36-44. PubMed ID: 23586673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.